Targeting myeloid-specific immune checkpoint inhibitors as a vulnerability in highly aggressive triple-negative breast cancer

Authors: Silvia Redondo Garcia
Publication:
Published: Aug 1, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

Hyperfiltration After Partial Versus Radical Nephrectomy for Localized Renal Tumors: A Systematic Review

Melchor Sean II Baesa, Rufino Agudera et al. - Aug 2026

Read More
Efficacy and safety of Neoadjuvant Chemoimmunotherapy Plus Chemoradiotherapy (NCRT) versus Chemoradiotherapy (CRT) Subsequent immune consolidation for Unresectable Stage III NSCLC: A Meta-Analysis

jiayi duan, jiaxi zheng et al. - Aug 2026

Read More
A 20 kA ±0.12% Pulsed Power Supply for the PIP-II ORBUMP Injection Dipole Magnets

H. Pfeffer, M. Davidson et al. - Jul 2026

Read More
Laboratory Tests of Astrophysical Black Hole Accretion Disk Plasma Models using the Z-machine at SNL

Patricia Cho, James Bailey et al. - Jul 2026

Read More
Towards a Verifiable Domain-Specific Language for Hardware-Accelerated Stencils

Damian Rouson, Xaokun Yang - Jul 2026

Read More
Journal Ideas PyMinds Charcha More
PORE

About

About Us

Resources

Help Centre Research Guides CiteScore

Legal

Terms of Service Privacy Policy Cookie Policy Accessibility

Connect

Contact Us
© 2026 PORE. Content available under CC BY-NC 4.0